IMVT vs INVA Stock Comparison
INVA currently leads IMVT in this stock comparison, with AIQ scores of 67 vs 52. The clearest difference is quality, while IMVT has the stronger momentum profile.
What is the main difference between IMVT and INVA?
INVA leads the current stock comparison as Innoviva, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Immunovant, Inc. vs Innoviva, Inc.
INVA leads
INVA leads by 15 AIQ points, primarily on Quality and Risk Resilience, but the lead has narrowed from 18 points over 30 sessions.
Fragile: 3 of 4 evidence groups support INVA, its lead is narrowing, and its current signal state is conflicted.
Immunovant, Inc.
Innoviva, Inc.
The Algovestiq AIQ Score currently favors INVA over IMVT, 67 versus 52 as of Nov 15, 2026. INVA's advantage is driven primarily by stronger quality and risk resilience, while IMVT holds the stronger momentum profile. INVA also shows the weaker technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor INVA today, and the comparison is rated Fragile on stability: the leader's advantage has been narrowing. INVA lead: Weakening — the AIQ differential moved from 18 to 15 points over 30 sessions.
Compare Immunovant, Inc. and Innoviva, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare IMVT and INVA against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality42 vs 76INVA +34
- Risk Resilience52 vs 74INVA +22
- Momentum61 vs 43IMVT +18
3 of 4 evidence groups favor INVA. INVA’s edge is concentrated in quality and risk resilience; IMVT keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +3
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.60x)
Largest factor move: Momentum +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 7 active signals are unchanged.
INVA's lead narrowed by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — IMVT and INVA both carry a full feed there.
The central trade-off
INVA (Innoviva, Inc.): the stronger current systematic profile, led by quality and risk resilience.
IMVT (Immunovant, Inc.): the counter-case, on momentum, technicals — but at materially higher volatility, 72.6% against 38%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
INVAINVA on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
INVAINVA on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
IMVTIMVT on the Momentum factor, by 18 points.
Lower downside
INVAINVA on Risk Resilience, by 22 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ Agreement Matrix
3 of 4 covered evidence groups favor INVA. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | INVA | 52 vs 67 |
| Fundamentals | INVAon balance | revenue growth -100% vs -11.3%; EPS growth 37.3% vs 9.6%; TTM ROE -14.8% vs -6.5%; gross margin 100% vs 73.9%; operating margin -74.9% vs 38.5% — INVA takes 3 of 5 decided legs, not all of them |
| Valuation | Not covered | Not covered |
| Technicals | IMVT | Price vs 50-day 4.7% vs -8.1%; vs 200-day 5.7% vs -13.1% |
| Risk Resilience | INVA | Risk Resilience 52 vs 74 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of IMVT and INVA and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is wide at 15 points. (supports the conclusion holding)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
- Signal direction runs against the verdict: the leader is net-bearish while the laggard is net-bullish. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on INVA.
How the comparison changed
120 daily snapshots · May 27 – Nov 13INVA lead: Weakening — the AIQ differential moved from 18 to 15 points over 30 sessions.
- Today
- INVA +15
- 52 vs 67
- 7 sessions ago
- INVA +20
- 49 vs 69
- 30 sessions ago
- INVA +18
- 49 vs 67
- 90 sessions ago
- IMVT +1
- 66 vs 65
The lead changed hands 3 times in this window, most recently on Aug 28 when INVA moved ahead of IMVT.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 3 bearish / 1 neutral, conflicted
Only IMVT
- Golden Cross Active — bullish, trend, long horizon (0.90%)
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.68%)
- Beta Spike Warning — bearish, risk_regime, long horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.60x)
- RSI Bearish Divergence — bearish, momentum, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
2 bullish / 4 bearish / 1 neutral, conflicted
Only INVA
- Death Cross Active — bearish, trend, long horizon (5.74%)
- 52-Week Low Proximity — bearish, risk_regime, long horizon (1.6%)
- ADX Trend Strengthening — neutral, trend, medium horizon
- Downtrend Structure Active — bearish, trend, long horizon
- Keltner Channel Breakdown — bearish, volatility, short horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-8.4%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
INVA leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -2.48%, AIQ +1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.32%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1IMVT closes the Quality gap — currently 34 points behind, the largest single contributor to INVA's edge.
- 2IMVT's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
- 3INVA's conflicting signal state resolves bearish — it currently carries 2 bullish and 4 bearish rules at once.
- 4The narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 15-point move would eliminate INVA's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
INVA leads on balance| Metric | IMVT | INVA |
|---|---|---|
| Revenue growth (YoY) | -100% | -11.3% |
| EPS growth (YoY) | 37.3% | 9.6% |
| Gross margin | 100% | 73.9% |
| Operating margin | -74.9% | 38.5% |
| Return on equity (TTM) | -14.8% | -6.5% |
| Debt to equity | 0 | 0.24 |
Performance
IMVT leads 5 of 6 windows| Metric | IMVT | INVA |
|---|---|---|
| 1 week (5 sessions) | 12% | -0.4% |
| 1 month (20 sessions) | 27.9% | -8.4% |
| 3 months (63 sessions) | -21.8% | -9.2% |
| 6 months (126 sessions) | 24.3% | -13.4% |
| Year to date | 34.5% | -4.8% |
| 1 year (252 sessions) | 45.8% | -14.6% |
Technicals
IMVT has the stronger structure| Metric | IMVT | INVA |
|---|---|---|
| RSI (14) | 58.1 | 33.1 |
| ADX (14) | 33.1 | 21.6 |
| Price vs 50-day | 4.7% | -8.1% |
| Price vs 200-day | 5.7% | -13.1% |
| Volatility (1M, annualized) | 72.6% | 38% |
Risk
INVA is the more resilient| Metric | IMVT | INVA |
|---|---|---|
| Beta | 1.58 | 0.31 |
| Sharpe ratio | 0.9 | -0.64 |
| Sortino ratio | 1.77 | -0.84 |
| Max drawdown | -40.5% | -22.2% |
| Current drawdown | -24% | -21.5% |
| Annualized volatility | 58.6% | 25.2% |
| Value at risk (95%) | -4.9% | -2.4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, IMVT or INVA?
On the Algovestiq AIQ Score, INVA is the stronger of the two as of Nov 15, 2026, scoring 67 against IMVT's 52. The edge comes from quality and risk resilience. IMVT is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is IMVT or INVA the better buy right now?
INVA carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the leader's advantage has been narrowing. Treat the lead as provisional.
Why does the AIQ Score favor INVA over IMVT?
The composite weights Quality, Value, Momentum and Risk Resilience. INVA leads Quality by 34 points; INVA leads Risk Resilience by 22 points; IMVT leads Momentum by 18 points. Where the two split, the factor with the larger weight carries the result.
Which is better value, IMVT or INVA?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, IMVT or INVA?
INVA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, IMVT or INVA?
IMVT on the Momentum factor, by 18 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, IMVT or INVA?
INVA is the more resilient of the two, so the other name carries the higher downside risk. INVA on Risk Resilience, by 22 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is IMVT more profitable than INVA?
The profitability evidence is mixed: gross margin 100% vs 73.9%; operating margin -74.9% vs 38.5%; ttm roe -14.8% vs -6.5%. IMVT leads on one measure and INVA on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is INVA's lead over IMVT getting stronger or weaker?
INVA lead: Weakening — the AIQ differential moved from 18 to 15 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 3 times in that window, most recently on 2026-08-28, when INVA moved ahead of IMVT.
What would change the IMVT vs INVA verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: IMVT closes the Quality gap — currently 34 points behind, the largest single contributor to INVA's edge; IMVT's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; INVA's conflicting signal state resolves bearish — it currently carries 2 bullish and 4 bearish rules at once; the narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 15-point move would eliminate INVA's advantage entirely.
What do the current signals say about IMVT and INVA?
IMVT: 4 bullish / 3 bearish / 1 neutral, conflicted. INVA: 2 bullish / 4 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on IMVT is Golden Cross Active (bullish, long horizon). On INVA it is Death Cross Active (bearish, long horizon).
Compare IMVT and INVA with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.